Newsroom

Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, today announces that it has sold Spanish leading concrete precast group Pretersa-Prenavisa to Precon, a subsidiary of Cementos Molins.   

Despite the mass rollout of vaccinations against the coronavirus, 2021 has continued to be a year of uncertainty, with new variants and question marks over vaccine efficacy leading to a seemingly continual tightening and loosening of restrictions worldwide. International travel has been disrupted, domestic political agendas are being rewritten but, above all, the lifeblood of Europe’s economies, its small and medium-sized businesses, are having to adapt their business models (in some cases significantly) in order to survive the pandemic and give themselves the room to thrive in its aftermath.

In August this year, Kartesia announced their investment in “Project Morel”, the acquisition and merger of Okechamp S.A. in Poland and Greenyard Prepared Foods in the Netherlands to form Okechamp Group. Kartesia committed a total of €78m debt and equity from its Kartesia Credit Opportunities Funds (KCO) IV & V. The capital injection was made with the aim of strengthening the group’s balance sheet, allowing it to pursue further organic and external growth and accelerate its international development. Headquartered in the Netherlands and Poland, Okechamp Group is Europe’s leading producer of highest quality preserved mushrooms with an annual production volume of over 115kt. The company operates a large mushroom farming unit in Poland and two mushroom processing units in Poland and the Netherlands, as well as distribution capabilities across more than 40 countries on six continents.

In December 2017, Kartesia employees voted to replace the year-end corporate gift with a donation to a project benefiting underprivileged children. Since then, we have donated to several non-profit organizations on an annual basis. In 2021, we donated to Etoiles du Sol, a French non-profit working for the benefit of underprivileged children in the North of Paris, mainly Saint Ouen. 

In 2021 the European CLO industry has been exceptionally busy, but is has also significantly developed in terms of ESG. Previously, we have witnessed the apparition of ESG negative screening provisions in EUR CLO new issuances and resets. While this year, we have seen managers introducing subjective ESG scoring across CLO portfolios as well as objective ESG reporting on CLO assets.

Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, is pleased to announce that it has provided a loan facility to support The Rohatyn Group (“TRG”) and the Founders of Optimapharm (“Optimapharm” or “the Company”) in the refinancing and growth financing of the Company.